-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The green synthesis technology development and industrialization project ofvitamin D ₃
₃
Vitamin D₃ series products, including VD₃ , 25- hydroxyVD₃ , 1α - hydroxyVD₃ , 1α ,25-dihydroxyVD₃, are the drugs of choice for the treatment of osteoporosis and other diseases, with global sales of US$2.
₃ ₃ ₃ ₃ ₃ ₃
In order to solve the above problems, after 13 years of joint research, the project team pioneered a new synthesis process for 25-hydroxy VD ₃ , comprehensively improved the production process level of VD ₃ , and invented selective hydroxylation, air catalytic oxidation, reduction and dehydration, etc.
₃ ₃
The project has obtained 12 invention patents from China, the United States, Europe, Japan, etc.
At present, the annual output of pure VD ₃produced by Zhejiang Garden Group reaches 75 tons, with a global market share of 40%; the annual output of pure 25-hydroxy VD ₃ is 15.
₃ ₃ ₃
In the past five years, the project has accumulated new sales of 1.